HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antoni L Andreu Selected Research

Glycogen Storage Disease Type V (McArdle's Disease)

4/2022Identification of Potential Muscle Biomarkers in McArdle Disease: Insights from Muscle Proteome Analysis.
12/2021Preclinical Research in McArdle Disease: A Review of Research Models and Therapeutic Strategies.
11/2020Data from the European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC).
1/2020Absence of p.R50X Pygm read-through in McArdle disease cellular models.
1/2019Low survival rate and muscle fiber-dependent aging effects in the McArdle disease mouse model.
10/2018Missense mutations have unexpected consequences: The McArdle disease paradigm.
1/2018Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics-based analysis in the McArdle mouse model.
5/2016Differential Muscle Involvement in Mice and Humans Affected by McArdle Disease.
1/2016Differential glucose metabolism in mice and humans affected by McArdle disease.
7/2015McArdle Disease: Update of Reported Mutations and Polymorphisms in the PYGM Gene.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antoni L Andreu Research Topics

Disease

22Glycogen Storage Disease Type V (McArdle's Disease)
04/2022 - 09/2003
6Muscular Diseases (Myopathy)
04/2022 - 01/2003
4Mitochondrial Diseases (Mitochondrial Disease)
01/2016 - 12/2002
3Glycogen Storage Disease (Glycogenosis)
05/2016 - 07/2012
2Contracture
04/2022 - 12/2014
2Inflammation (Inflammations)
01/2019 - 07/2016
2Neoplasms (Cancer)
12/2017 - 09/2013
2Cachexia
12/2017 - 09/2013
2Ophthalmoplegia (External Ophthalmoplegia)
04/2013 - 01/2011
2Proteinuria
04/2013 - 07/2007
2Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked)
12/2012 - 10/2011
2Hearing Loss (Hearing Impairment)
11/2011 - 08/2010
2Stroke (Strokes)
12/2003 - 01/2003
1Myoglobinuria
11/2020
1Fibrosis (Cirrhosis)
01/2019
1Disease Progression
01/2019
1Chronic Disease (Chronic Diseases)
12/2017
1Atrophy
12/2017
1Adenocarcinoma
12/2017
1Lung Neoplasms (Lung Cancer)
12/2017
1Fatigue
12/2014
1Myocardial Infarction
01/2014
1Cross Infection (Nosocomial Infection)
01/2014
1Sarcopenia
12/2013
1Parkinson Disease (Parkinson's Disease)
08/2013
1Parkinsonian Disorders (Parkinsonism)
08/2013
1Muscular Dystrophies (Muscular Dystrophy)
05/2013
1Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
05/2013
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
04/2013
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2012
1Inborn Genetic Diseases (Disease, Hereditary)
07/2012
1Recurrent Myoglobinuria
03/2012
1Body Weight (Weight, Body)
01/2012
1Communicable Diseases (Infectious Diseases)
11/2011
1Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia)
01/2011
1Methylmalonic acidemia
06/2010
1Lactic Acidosis
06/2010
1Acidosis
06/2010
1Fever (Fevers)
07/2007
1Hematuria
07/2007
1Myalgia
07/2007
1Lipomatosis
11/2006
1Lipoma (Lipomata)
11/2006

Drug/Important Bio-Agent (IBA)

13Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA
04/2022 - 09/2003
13Mitochondrial DNA (mtDNA)IBA
12/2017 - 12/2002
9GlycogenIBA
12/2021 - 05/2015
7Protein Isoforms (Isoforms)IBA
04/2022 - 10/2008
7Muscle Form Glycogen Phosphorylase (Myophosphorylase)IBA
01/2018 - 09/2003
6Proteins (Proteins, Gene)FDA Link
04/2022 - 12/2002
4EnzymesIBA
06/2015 - 10/2008
3Creatine Kinase (Creatine Phosphokinase)IBA
11/2020 - 07/2007
3Proteasome Endopeptidase Complex (Proteasome)IBA
12/2017 - 09/2013
2UbiquitinIBA
12/2017 - 07/2016
2Tyrosine (L-Tyrosine)FDA Link
12/2017 - 07/2016
2Myosins (Myosin)IBA
12/2017 - 07/2016
2Glucose (Dextrose)FDA LinkGeneric
05/2016 - 01/2016
2Oxygen (Dioxygen)IBA
09/2013 - 08/2007
2NucleotidesIBA
05/2013 - 11/2011
2AntioxidantsIBA
12/2012 - 10/2011
2Nonsense Codon (Nonsense Mutation)IBA
07/2012 - 02/2008
2DNA (Deoxyribonucleic Acid)IBA
02/2007 - 12/2002
2Lys Transfer RNAIBA
11/2006 - 01/2003
1Biomarkers (Surrogate Marker)IBA
04/2022
1ProteomeIBA
04/2022
1atalurenIBA
01/2020
1amlexanox (Aphthasol)FDA Link
01/2020
12- imino- 5- ((5- (2- nitrophenyl)furan- 2- yl)methylene)thiazolidin- 4- oneIBA
01/2020
1antibiotic G 418IBA
01/2020
1PolymersIBA
12/2017
1Muscle Proteins (Muscle Protein)IBA
12/2017
1Adenosine Diphosphate Ribose (ADP-Ribose)IBA
12/2017
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
12/2017
1Ligases (Synthetase)IBA
12/2017
1Superoxide DismutaseIBA
07/2016
1Bortezomib (Velcade)FDA Link
07/2016
1ThymidineIBA
01/2016
1DeoxyuridineIBA
01/2016
1glucose-1-phosphateIBA
07/2015
1Valproic Acid (Depakote)FDA LinkGeneric
05/2015
1AntigensIBA
01/2014
1MyostatinIBA
12/2013
1DNA Polymerase gammaIBA
08/2013
1Levodopa (L Dopa)FDA LinkGeneric
08/2013
1Karyopherins (Importin)IBA
05/2013
1Terminator Codon (Termination Codon)IBA
05/2013
1Asn Transfer RNAIBA
04/2013
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
04/2013
1Mitochondrial Permeability Transition PoreIBA
12/2012
1Cyclophilins (Cyclophilin)IBA
12/2012
1Member 1 Subfamily D ATP Binding Cassette TransporterIBA
12/2012
1Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA
01/2012
1CalciumIBA
01/2012
112S ribosomal RNAIBA
11/2011
1Anti-Bacterial Agents (Antibiotics)IBA
11/2011
1AminoglycosidesIBA
11/2011
1Pyruvate KinaseIBA
10/2011
1Ala Transfer RNAIBA
01/2011
1Cytochromes c (Cytochrome c)IBA
01/2011

Therapy/Procedure

1Therapeutics
05/2016
1Activities of Daily Living (ADL)
12/2006